Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2022-03-02
Product name
DYAZIDE CAPSULES
Product Synonyms
DYAZIDE CAPSULES 25 MG/37.5 MG * TRIAMTERENE AND HYDROCHLOROTHIAZIDE, FORMULATED PRODUCT
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline Canada
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Section 2
Physical hazards
Not classified.
Health hazards
Specific target organ toxicity following single Category 3 respiratory tract irritation exposure
Environmental hazards
Hazardous to the aquatic environment, Category 4
Signal word
Warning
Hazard statements
May cause respiratory irritation. May cause long lasting harmful effects to aquatic life.
Prevention
Avoid breathing dust. Avoid breathing vapours. Use only outdoors or in a well-ventilated area. Avoid release to the environment.
Response
IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTRE/doctor/ if you feel unwell.
Storage
Store in a well-ventilated place. Keep container tightly closed. Store locked up.
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations.
2.3 Other hazards
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
Additional information
7 % of the mixture consists of component(s) of unknown acute oral toxicity. 99 % of the mixture consists of component(s) of unknown acute dermal toxicity. 99 % of the mixture consists of component(s) of unknown acute inhalation toxicity. 98 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 98 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
